Brokerages expect that Tivity Health Inc (NASDAQ:TVTY) will report sales of $152.59 million for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Tivity Health’s earnings, with the lowest sales estimate coming in at $151.42 million and the highest estimate coming in at $153.50 million. Tivity Health posted sales of $138.91 million during the same quarter last year, which would indicate a positive year over year growth rate of 9.8%. The company is expected to issue its next quarterly earnings results after the market closes on Thursday, August 2nd.
On average, analysts expect that Tivity Health will report full-year sales of $613.51 million for the current fiscal year, with estimates ranging from $609.60 million to $617.90 million. For the next year, analysts forecast that the firm will post sales of $671.83 million per share, with estimates ranging from $649.79 million to $684.80 million. Zacks’ sales calculations are an average based on a survey of analysts that follow Tivity Health.
Tivity Health (NASDAQ:TVTY) last announced its quarterly earnings results on Monday, April 23rd. The company reported $0.49 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.49. Tivity Health had a net margin of 12.33% and a return on equity of 28.62%. The company had revenue of $149.90 million during the quarter, compared to the consensus estimate of $154.32 million. During the same quarter in the previous year, the company posted $0.42 earnings per share. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year.
Several equities research analysts recently weighed in on the stock. ValuEngine downgraded shares of Tivity Health from a “hold” rating to a “sell” rating in a report on Saturday, June 2nd. Zacks Investment Research downgraded shares of Tivity Health from a “buy” rating to a “hold” rating in a report on Thursday, April 26th. BidaskClub downgraded shares of Tivity Health from a “buy” rating to a “hold” rating in a report on Friday, April 13th. Chardan Capital raised shares of Tivity Health from a “neutral” rating to a “buy” rating and set a $42.00 price objective for the company in a report on Monday, June 4th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and issued a $49.00 price objective on shares of Tivity Health in a report on Tuesday, April 24th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $47.75.
Shares of Tivity Health traded up $0.17, hitting $35.93, during midday trading on Wednesday, according to MarketBeat.com. 162,453 shares of the stock traded hands, compared to its average volume of 724,392. Tivity Health has a 1-year low of $29.95 and a 1-year high of $48.50. The company has a market cap of $1.43 billion, a price-to-earnings ratio of 21.38, a price-to-earnings-growth ratio of 1.51 and a beta of 0.45.
In other news, CEO Donato Tramuto sold 20,000 shares of the stock in a transaction that occurred on Tuesday, May 1st. The stock was sold at an average price of $35.37, for a total value of $707,400.00. Following the completion of the sale, the chief executive officer now directly owns 149,596 shares of the company’s stock, valued at $5,291,210.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.73% of the stock is owned by corporate insiders.
A number of institutional investors have recently added to or reduced their stakes in the business. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Tivity Health in the first quarter valued at $333,000. Amalgamated Bank bought a new position in Tivity Health in the first quarter valued at about $209,000. Principal Financial Group Inc. boosted its holdings in Tivity Health by 0.6% in the first quarter. Principal Financial Group Inc. now owns 289,546 shares of the company’s stock valued at $11,480,000 after acquiring an additional 1,790 shares during the last quarter. WINTON GROUP Ltd bought a new position in Tivity Health in the first quarter valued at about $1,487,000. Finally, Xact Kapitalforvaltning AB bought a new position in Tivity Health in the first quarter valued at about $227,000.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Get a free copy of the Zacks research report on Tivity Health (TVTY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.